{"id":"W2029712223","doi":"10.1038/bjc.2012.21","title":"A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Medical Association","funders":"National Cancer Institute; Moffitt Cancer Center","keywords":"Carboplatin; Medicine; Etoposide; Adverse effect; Clinical endpoint; Internal medicine; Chemotherapy; Anesthesia; Clinical trial; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003894503,0.0001792455,0.0006775237,0.0002520599,0.00005401245,0.00003585549,0.00008102573,0.00007344389,0.00005958423],"category_scores_gemma":[0.0001716048,0.0001378852,0.00004567183,0.000359984,0.0001484369,0.0002745178,0.00004969057,0.0004312037,1.337599e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005911192,"about_ca_system_score_gemma":0.00116631,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.007174488,"about_ca_topic_score_gemma":0.01923943,"domain_scores_codex":[0.9980013,0.0001186953,0.0006289557,0.0001876244,0.0006902232,0.0003732103],"domain_scores_gemma":[0.9984204,0.00009778581,0.0005710302,0.0001122653,0.0005972552,0.0002012454],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1994275,0.002921676,0.7541454,0.0008595242,0.0002188827,0.0008216755,0.002436029,0.00001411028,0.0009472542,0.000003166686,0.0003104115,0.0378944],"study_design_scores_gemma":[0.3768347,0.01275727,0.5977963,0.007735102,0.0002943644,0.0001791571,0.0007822277,0.00007367639,0.002498544,0.000003696428,0.0007702663,0.0002746535],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880829,0.009798463,0.000006825564,0.0002357587,0.0001705468,0.00147335,0.00006903321,0.000004671061,0.0001584062],"genre_scores_gemma":[0.9951767,0.003926904,0.0001823694,0.0001292738,0.0001478421,0.0001128855,0.00000671373,0.00003099684,0.0002862769],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1774072,"threshold_uncertainty_score":0.9994368,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02277835739252881,"score_gpt":0.3474266205460649,"score_spread":0.3246482631535361,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}